Biotech Startups

InDevR develops off-the-shelf and custom analytical testing solutions, including its VaxArray microarray platform and multiplex immunoassays, for the development, optimization, and manufacturing of mRNA-, protein-, polysaccharide, conjugate, and viral vector-based vaccines. It serves vaccine developers and manufacturers with GMP- and 21 CFR Part 11-compliant assays used across R&D, clinical trials, and release testing.

1 investor

Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech. The company focuses on drug candidates targeting ovarian and pancreatic cancer.

1 investor

IndieBio was a startup accelerator and pre-seed investment program launched by SOSV in San Francisco in 2015, providing on-site bio-labs and funding to science founders across biotech, food, agriculture, industrial decarbonization, AI, therapeutics, and diagnostics. As of 2026 the program was rebranded to SOSV NY and SOSV SF, expanding its focus from bio to broader deep tech.

1 investor

Indigo BioAutomation provides software tools that use machine learning and artificial intelligence to improve laboratory operations and data analysis across multiple industries. The platform helps scientists accelerate their research work and decision-making through collaborative tools and data-driven insights.

1 investor

IndiTreat is a CE IVD-marked functional drug sensitivity test that uses patient-derived tumor organoids to guide personalized treatment decisions for metastatic colorectal cancer (mCRC) patients. It is aimed at healthcare professionals and oncologists as a complement to traditional biomarker testing.

1 investor

Infera converts natural language descriptions of lab experiments into executable protocols for laboratory instruments, managing protocol logic, vendor-specific configurations, data, and inventory across an integrated system.

1 investor

A consortium and organization working to accelerate the development of therapeutics, vaccines, and products to combat antimicrobial resistance (AMR) through multiple innovation platforms. The organization supports industry partners, particularly early-stage biotech startups, in advancing solutions to address this global health crisis.

1 investor

Infius Health manufactures in-vitro diagnostic kits that automate manual medical testing procedures. The company serves healthcare providers and laboratories requiring diagnostic solutions.

1 investor

Inflamalps is a biopharmaceutical company discovering anti-inflammatory and anti-microbial molecules, with its lead candidate INF101 targeting dry eye disease in ophthalmology. Since 2020 it has run a drug discovery program for novel anti-microbial molecules in partnership with academic and CRO partners across Europe and New Zealand.

1 investor

Info Edge is a platform that invests in and operates early-stage internet ventures across multiple sectors including food delivery, insurance comparison, printing, SaaS, agriculture, healthcare, logistics, and edtech. The company provides financial and strategic support to portfolio companies to create and scale online businesses.

1 investor

InformedDNA applies genetics expertise and technology to deliver genomics insights and services such as telegenetic counseling for payors, healthcare providers, and patients across the US. It operates in the digital health and genomics space, supporting clinical decisions around screening, diagnosis, and treatment.

1 investor

Informuta provides predictive infection intelligence tools that forecast antibiotic resistance risk to help clinicians prevent treatment failures and optimize antibiotic prescribing decisions. The company serves healthcare providers and infectious disease practitioners with AI-driven diagnostics and bacterial evolutionary analytics.

1 investor

InfuSense develops an electrochemical sensing technology platform that detects analytes at sub-therapeutic levels, delivering sample analysis results within minutes. The portable device is designed to bring laboratory-scale testing capabilities into a handheld form factor.

1 investor

IngateyGen develops peanut varieties engineered for improved safety and nutritional value, aiming to reduce the risk of peanut allergies. The company partners with the food value chain to bring these products to market for consumers, particularly families concerned about allergic reactions.

1 investor

1 investor

Ingelia develops biochar and related bioproducts from waste through hydrothermal carbonization (HTC) technology, serving agricultural, energy, and industrial sectors. The company produces biochar for soil conditioning, bioenergy fuels, bio-coke for steel production, and other specialized bioproducts with reduced carbon emissions.

1 investor

InGeno develops personalized genetic tests based on DNA analysis, providing individuals with information about their predispositions related to nutrition, sports, health, skin, and hair. Customers order a test online, receive a home collection kit, and get a report with the option to consult an expert.

1 investor

IngredientWerks is a molecular farming company that engineers plants to produce plant-based proteins and ingredients for the alternative protein market. It develops these ingredients as substitutes for conventional proteins, targeting food and nutrition applications.

1 investor

Ingrediome produces meat and fish made from real muscle proteins, using sunlight and CO2 captured from the air to create nature-identical products decoupled from animal agriculture. It targets meat consumers seeking healthier and more sustainable alternatives with the taste and texture of traditional meat.

1 investor

Inhalis Therapeutics researches and develops inhaled treatments for Idiopathic Pulmonary Fibrosis and other life-threatening diseases, using inhalation delivery technology. It focuses on providing safer and more effective therapy options for patients.

1 investor

Inimmune is a clinical-stage biotech company developing immunotherapies for allergy, cancer, infectious, and autoimmune diseases. The company combines immunology and vaccine expertise to advance its clinical and pre-clinical pipeline.

1 investor

Inka's Berries develops new blueberry varieties and produces fresh blueberries for export through two business divisions focused on genetic innovation and cultivation. The company operates in Peru with operations spanning genetic research, farming, packing, and international distribution.

1 investor

INKE develops and manufactures active pharmaceutical ingredients (APIs), including high-potency APIs and ophthalmic solutions, using chemical synthesis and micronization technologies. It operates two cGMP manufacturing sites with capabilities in crystal engineering, chromatographic purification, and high-containment handling.

1 investor

InkVivo Technologies develops polymer-based drug delivery platforms (GARD/gastroretentive and SHEALD/injectable) for controlled, localized, and sustained release of small molecules and biologics. An ETH Zurich spin-off, it works with pharmaceutical and nutraceutical partners to improve bioavailability and patient adherence, with programs targeting iron deficiency anemia and neurodegenerative diseases.

1 investor